Abstract
Introduction
ET-1 is a potent vasoconstrictor peptide secreted by vascular endothelial cells. It belongs to a family of closely related peptides that comprise three mammalian isoforms Ž . ET-1, ET-2 and ET-3 and snake venom toxins, the sarafotoxins. It is now well established that ETs are distributed in a large variety of organs and tissues. Their actions are mediated by their interaction with specific cell surface receptors of their target cells. Two receptors for ETs have been identified by molecular cloning techniques w x 1,2 . The ETA receptor mainly recognises ET-1 and ET-2. It is selectively antagonized by BQ-123. The ETB receptor binds with equal affinity to the different ET isoforms.
Ž . Corresponding author. Tel.: q33 4 93957755; fax: q33 4 93957708; e-mail: frelin@unice.fr ETs are probably involved in the pathogenesis of some w x cardiovascular and renal diseases 3-7 . Evidence comes mainly from the fact that these conditions are associated to w x elevated circulating or urinary ET-1 levels 8 . It is, however, increasingly clear that circulating ET-1 levels are not representative of the real amount of ET present in tissues.
Ž w x. For instance, plasma ET-1 levels 1-25 pM 8 are too low to induce contractions in isolated vessel preparations. Conversely, mixed receptor antagonists which abolish peripheral vasoconstrictions in response to the infusion of w x ET-1, increase plasma immunoreactive ET-1 9-11 .
We previously suggested that a local action of ETs could be favoured by the fact that the K value of ET-1 d receptor complexes is much lower than the concentration Time for primary review 22 days.
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Stoichiometric binding can account for many unusual features of ET actions such the fact that ET-1 qry transgenic mice w x have a higher blood pressure than ET-1 qrq mice 13 , the presence of exceedingly low circulating levels of the w x peptides 8 and the fact that receptor antagonists act as w x clearance antagonists 9-11 . One essential feature of this model is that most ligand molecules cannot exist in a free state and must be bound onto receptors. Tissue ETs have been documented by cytochemical techniques. ETs have also been extracted from tissues under strong denaturing conditions. Although these techniques do indicate the presence of ETs in tissues, they provide no information about Ž . their form free or bound and about the receptors that are occupied.
The objective of this study was to devise a technique for assessing receptor bound ETs in tissues. It is based on the fact that ETs and their receptors form tight complexes that hardly dissociate at neutral pH. When binding experiments are performed on homogenate preparations, endogenous ETs that are already bound onto receptors, remain associated to the receptors and mask these sites to radiolabelled ligands. The masking of receptors by endogenous ET-1 is well recognized in cell culture systems. For instance, it has been reported that blocking the maturation of big ET-1 into ET-1 by phosphoramidon decreases the endogenous production of ET-1 by cultured cells and up w x regulates ET receptors 14 . In this paper we first defined conditions that induced a reversible denaturation of ET receptors and the dissociation of endogenous ETs from their receptors. We then applied these conditions to tissues from normal rats. The results indicated that the status of ET receptors was not identical in renal and cardiac tissues. Most receptors in cardiac tissues were available to exogenous ET-1. Only half of renal receptors was available to ET-1.
Methods

Materials
Biochemical reagents were from Sigma Chemical Co. unless otherwise indicated. ET-1 and BQ-123 were pur-Ž .w 125 x chased from Neosystems Strasbourg, France .
I ET-1 Ž . 2200 Cirmmol was obtained from Amersham Corp. or prepared using Chloramine T and purified by high pressure w x liquid chromatography 15 . A rat ETB receptor cDNA clone was kindly provided by Dr. M. Yanagisawa. A bovine ETA receptor cDNA clone was kindly provided by Dr. S. Nakanishi.
Earle's salt solution was 140 mM NaCl, 5 mM KCl, 1.8 mM CaCl , 0.8 mM MgCl buffered at pH 7.5 with 25 2 2 mM HepesrTris. In some experiments, the pH of the solution was brought to 2.5 with 25 mM glycinerHCl. Homogenization buffer was 250 mM sucrose, 1 mM EDTA buffered at pH 7.5 with 10 mM TrisrCl. All solutions Ž were supplemented with a cocktail of protease inhibitors 1 mM leupeptine, 0.1 mM bacitracin and 0.1 mM phenyl-. methyl-sulphonyl fluoride .
Cell cultures
Stable transfectant CCl39 fibroblasts expressing bovine Ž . ETA receptors ETArCCl39 cells and rat ETB receptors Ž . w x ETBrCCl39 cells , prepared as previously described 16 , were kindly provided by Dr. J. Pouyssegur. Cells were grown in Dulbecco's modified Eagle's medium supple-Ž mented with 10% fetal bovine serum Dutscher, Stras-. bourg, France , 100 unitsrml of penicillin and 100 mgrml of streptomycin. Rat brain capillary endothelial cells were w x grown as previously described 17 .
To prepare cell homogenates, confluent monolayers were washed with serum free culture medium, scrapped with a rubber policeman into the homogenization buffer Ž and homogenized with a Polytron 3 times 5 s at position . 6 . All operations were performed at 48C. Homogenates were stored at y208C.
Tissue preparation
Ž . Wistar rats 200 g from both sexes were killed by cervical dislocation. Tissues were rapidly excised, and washed with ice cold Earle salt's solution. Tissues were Ž minced with scissors and homogenized with a Polytron 3 . times 5 s at position 10 in homogenization buffer. All operations were performed at 48C. Proteins were deterw x mined according to Bradford 18 . Homogenates were stored at y208C.
In some experiments, rats were anesthetized with pento-Ž barbital and a bolus injection of phosphoramidon 7
. mmolrkg was given in the tail vein. Control animals were injected with the same volume of saline. Animals were then returned to their home cage for 16 h and a second injection of phosphoramidon or of saline was given. Animals were killed 4 h later and renal homogenates were prepared as described above. . 67 mgrml, cell homogenates: 10 mgrml .
Acid wash
ET extraction and assay
Ž
Neutralized kidney extracts 4 animals in each experi-. ment were centrifuged at 120 000 g for 45 min. Supernatants were neutralized with Tris and passed through Ž . activated SepPak C18 cartridges Waters . Columns were Ž . washed twice with 4 ml of 0.1% trifluoroacetic acid TFA Ž . and 0.05% triethylamine TEA in water and then with 4 ml of 20% acetonitrile, 0.1% TFA and 0.05% TEA. ETs were then eluted with 4 ml 50% acetonitrile, 0.1% TFA and 0.05% TEA. Fractions were lyophilized and the residue was dissolved into 0.1 ml of Earle's salt solution supplemented with 0.05% bovine serum albumin. ET was then Ž . assessed by radioimmunoassay Amersham kit , receptor assay or functional assays. The receptor assay was perw x formed as previously described 17 and using membranes prepared from ETB receptor expressing fibroblasts. Funcw x tional assays were performed using rat aortic strips 19 .
Data analysis
Binding isotherms were analyzed using the Ligand software to yield apparent K values and maximum binding d capacities. Means " SEM and the number of animals used are indicated. Statistical significance of the differences was assessed using t tests. All animals used were housed and handled under protocols approved by the Institutional Animal Care and Use Committees.
Results
[ 125 ]
Acid induced dissociation of I ET-1 receptor complexes
It is well known that complexes formed by ETs and their receptors are very stable and that an acidification w x promotes their dissociation 20 . We first defined condiw 125 x tions that promoted dissociation of preformed I ET-1 receptor complexes. Experiments were performed using rat brain capillary endothelial cells which expressed ETA w x receptors 17,21 and CCl39 fibroblasts that were transfected with rat ETB receptors.
We first checked that ET-1 formed tight complexes with rat ETA and ETB receptors and that in 90 min w 125 x dissociation experiments, less that 10% of I ET-1 bound onto rat ETA or ETB receptors was released by 100 nM unlabelled ET-1. Fig. 1 shows that an acidification to pH w 125 x 2.5 induced a rapid dissociation of preformed I ET-1 ETA receptor complexes which was nearly complete after w 125 x 20 min. Fig. 1 also shows that dissociation of I ET-1 ETB receptor complexes proceeded much more slowly and that after a 90 min incubation at pH 2.5 only 70% of the complexes had dissociated. This result agrees with the w 125 x Fig. 1 . Acid induced dissociation of I ET-1 from ETA and ETB receptors. Homogenates prepared from ETA receptor expressing endothe-Ž . Ž . lial cells`and from ETBrCCl39 cells v were prepared and w 125 x equilibrated with 20 pM I ET-1. After 90 min, the incubation solution was acidified to pH 2.5 and dissociation of the preformed complexes was followed. Data were normalized to the specific binding component measured before the acidification. Dissociations did not follow monoexponential kinetics. known greater stability of ET-1 ETB receptor complexes. Incubating cell homogenates at pH values -2.5 induced a w 125 x faster and more complete dissociation of I ET-1 from ETB receptors but it irreversibly damaged the receptors. Incubating cell homogenates at pH values ) 2.5 induced a w 125 x slower dissociation of I ET-1 from ETB receptors. A 90 min exposure of homogenates to pH 2.5 was used in all subsequent experiments.
Acid treated ETA and ETB receptors renature after neutralization
Properties of acid washed ETA and ETB receptors were then analyzed. Figs. 2 and 3 compare ET-1 binding isotherms for ETA and ETB receptors in control ho-Ž . mogenates and in homogenates that have been acid washed and neutralized. They show that the acid treatment did not modify the apparent affinity of ET-1 for its two receptors. It did not modify maximum ET-1 binding capacities. Taken together, these indicated that the conditions chosen were mild enough to allow a full renaturation of ETA and ETB receptors after neutralization. 
An acid wash unmasked new receptor sites in renal tissues
We then applied the acid wash technique to rat tissues. Tissue homogenates were prepared from different organs of normal rats. Half of the preparation from each animal was acid treated as described above. The other half served as a control. Following neutralization, receptors were w 125 x titrated and the specific I ET-1 binding component was compared to that obtained in control homogenates that had Homogenates were acid washed and neutralized as described in the w 125 x Methods section. ET receptors were then titrated using 20 pM I ET-1. The specific binding component in acid treated tissues was expressed relative to the value obtained in preparations from the same animal that were not acid treated. Means"SEM and the number of animals used are indicated.
not been acid treated. Table 1 shows that an acid treatment w 125 x had no action on I ET-1 binding to brain, liver and lung w 125 x homogenates. It increased I ET-1 binding to myocardial homogenates 1.3 fold. The difference was not statistically significant.
Acidification of whole kidney homogenates increased w 125 x Ž . Ž . I ET-1 binding 2.18 " 0.14 fold n s 38 Table 1 . We also noticed a large variability in the responses. No w 125 x increase in I ET-1 binding was observed in two aniw 125 x mals. In responsive animals, stimulation of I ET-1 binding by the acid wash ranged from 1.4 to 4.6 fold.
w 125 x Fig. 5 compares I ET-1 binding to control and acid washed homogenates prepared from renal cortex and Ž . w 125 x medulla. It shows i that I ET-1 binding was larger in Ž . the medulla than in the cortex and ii that an acid wash w 125 x revealed more I ET-1 binding sites in homogenates prepared from the medulla than in homogenates prepared from the cortex. Thus masked renal ET receptors are mainly localized in the renal medulla. I ET-1 titrated both ETA and ETB receptors in acid washed homogenates.
Properties of masked renal ET receptors
The relative proportions of ETA and ETB receptors in control and acid washed renal homogenates were evaluated . 1 and that the proportion of masked ETB receptors may be slightly higher than 28%. Finally relative densities of masked ETA and ETB receptors were estimated from the acid inducible BQ-123 w 125 x sensitive and insensitive I ET-1 bindings. Results indicated masked receptors consisted of 46 " 10% ETA recep-Ž . tors and 54 " 10% ETB receptors n s 18 . In other words, endogenous ETs bind equally to ETA and ETB receptors but the density of ETA receptors being less than that of ETB receptors, a larger fraction of ETA receptors is occupied by endogenous ETs.
Influence of phosphoramidon on renal ET receptors
Phosphoramidon inhibits conversion of big ET-1 into w x ET-1 by endothelin converting enzyme 24 and can be used to decrease tissue ET. Rats were injected with phosphoramidon and renal ET receptors were titrated 20 h later.
w 125 x Fig. 8 shows that I ET-1 binding to untreated kidney homogenates prepared from control and phosphoramidon treated animals were similar. An acid wash increased w 125 x I ET-1 binding in the two groups of animals but the increase ET-1 receptor density in phosphoramidon treated animals was lower than in controls. Thus phosphoramidon treatment decreased densities of both total and masked ET receptors in renal homogenates.
Extraction of endogenous ETs from renal tissues
Provided that masked receptors were receptors that had been freed of bound ETs, the amount of receptor bound ET was estimated to 300 fmolrmg of proteins, i.e. about 10 pmol per kidney. This value is close to the amount of ET-1 that can be extracted from kidney samples under strong w x denaturing conditions 25 . Ž Different assays RIA, receptor assays and functional . assays were used to assay free ET in renal extracts. The Ž . results indicated i undetectable ET levels in neutral kid-Ž . ney extracts and ii the presence of low amounts of ET in Ž . acid extracts 3-5 fmolrmg of protein . This amount was much lower than that expected from the density of masked Ž . sites 300 fmolrmg of protein . The main reason for this difference was that ET-1 released from the receptors was degraded at pH 2.5. This was checked by an experiment in which a kidney homogenate was incubated for 90 min at pH 2.5 in the presence of a known amount of exogenous ET-1. This amount was only partially recovered after neutralization of the extract and purification of ET-1. We further checked that aqueous solutions of ET-1 were stable at pH 2.5 and that degradation of the peptide by kidney homogenates was reduced at pH 7.5. One hypothesis for these results could be that lysosomal proteases were activated at pH 2.5 and degraded endogenous ETs. Because of these difficulties, it was not possible to relate the amount of masked ET receptors and the concentration of endogenous ET in tissues. 
Discussion
Results presented in this paper indicate the presence in w 125 x Ž . rat tissues of two forms of I ET-1 binding sites: i sites that are freely accessible to the radiolabelled ligand and Ž .
ii binding sites that become accessible to the radiolabelled ligands only after an acid treatment of the homogenates. Masked sites were only observed in renal Ž . tissues Table 1 ; they were mainly localized in renal Ž . medulla Fig. 6 and may be of the ETA or ETB subtype Ž . Fig. 7 . Masked receptors were not observed in trans-Ž . fected fibroblast cell lines Figs. 2 and 3 . They were observed in capillary endothelial cells that expressed pre-Ž . pro ET-1 mRNAs Fig. 4 . Different hypotheses may account for the existence of masked receptors. First it could be that the acid treatment induced a conformational change of the receptors and unmasked inactive, but ET free binding sites. This hypothesis was unlikely for the acid treatment did not unmask binding sites in fibroblasts and had different actions in different rat tissues. Another hypothesis could be that ET-1 was stored by the cells, was released during homogenization and masked receptor sites after homogenization of the tissues. Although an intracellular storage of ET-1 by endothelial cells has been w x documented 26,27 , this hypothesis is unlikely to account for our results in kidney membranes for no detectable ET could be recovered in neutral kidney extracts. Another hypothesis is that masked ET receptors were receptors that were occupied by endogenous ETs. This hypothesis is supported by the fact that phosphoramidon, an inhibitor of w x endothelin converting enzyme 24 decreased the density Ž . of masked renal receptors Fig. 8 . The fact that important amounts of ETs are associated to their receptors in renal tissues and cannot be extracted from the tissues under mild conditions provides direct support of our hypothesis that stoichiometric binding conditions determine local actions w x of ETs 12 .
The most important observation of this paper is that the status of ET receptors is different in renal and cardiac tissues. While about 50% of renal ET receptors are occupied by endogenous ETs, most cardiac receptors are avail-Ž . able to exogenous ET-1 Table 1 . This suggested that the kidney but not the heart is an important site of action of ETs in normal rats. This conclusion is consistent with results showing that ET receptor antagonists have no acw x tion on cardiac hemodynamics 28 but markedly altered w x renal function in normal rats 29-31 . The absence of receptor bound ETs in heart tissues also suggests that cardiac receptors are unlikely to be desensitized. This could mean a larger sensitivity of the heart to ETs. It should further be stressed that ET has two actions on receptors. First ET regulates expression of receptors w x 14,15 . This action determines the total density of sites Ž . free and masked . Second, ET binds to receptors and masks receptors to exogenous ET-1. This action determines the density of masked sites. Therefore, a measure of the fraction of masked sites in a membrane preparation cannot be used as a measure of endogenous ETs.
This study further confirms the presence in renal tissues of both ETA and ETB receptors. As observed previously w x 4 , ETB receptors are more abundant than ETA receptors. The two receptors have different cellular localization and probable functions. ETB receptors are localized in arterioles, glomeruli, proximal convoluted tubule, medullary w x thick ascending loop and collecting duct 32 . ETB receptors in glomerular endothelial cell couple to NO and prostaglandin syntheses, i.e. to vasorelaxing mechanisms w x 33 . ETB receptors in distal segments of tubules are w x natriuretic 31 . ETA receptors are localized in arterioles, w x glomeruli and proximal straight tubule 31 . They probably w x w x mediate vasoconstrictor 30,34 and antinatriuretic 29,31 actions of the peptide. Renal synthesis of ETs has been documented in glomerular endothelial cells, mesangial cells and epithelial cells of the proximal tubule, medullary thick ascending limb, medullary collecting duct and cortical w x collecting tubule 35 . Results presented in this paper further suggested that as much as 50% of renal ET receptors are occupied by endogenous ETs and that most of these receptors seem to be localized in the renal medulla.
Ž . Endogenous ETs about 300 fmolrmg of protein bind equally to ETA and ETB receptors. Yet, the density of ETA receptors being less than that of ETB receptors, a larger fraction of ETA receptors than of ETB receptors is occupied by endogenous ETs. These could suggest a preferential activation of ETA receptors by endogenous ETs. This hypothesis is consistent with the observation that bosentan, a mixed receptor antagonist, has the same renal actions as BQ-123, an ETA receptor selective antagonist w x 30 . Further studies are required to define which kidney cells bind endogenous ETs.
w 125 x Intravenously injected I ET-1 disappears from the circulation with a half life of 1-2 min. The label accumuw x lates in lung, kidney and liver tissues 36,37 . Evidence using receptor antagonists have further suggested that ETB receptors play an important role in the clearance of ET-1 w x 9-11 . Results presented in this paper indicate the presence of receptor bound ETs in kidney but not in lung and Ž . liver tissues Table 1 . This does not mean that pulmonary ET-1 clearance is not receptor mediated. ETs bound to ETB clearance receptors may be rapidly internalized and degraded. Conversely, the existence of masked ET receptors in kidney tissues does not mean that these receptors are involved in the clearance of ET-1. Whether ETs bound to renal receptors have a local or systemic origin cannot be defined from our experiments.
In conclusion, this study indicates that an important fraction of renal ET receptors are not accessible to exogew 125 x nous I ET-1. They become available to labelled ligands only after an acid wash of homogenates. All available evidence suggests that these masked sites are receptors that have bound endogenous ETs. The status of ET receptors is not identical in kidneys and hearts. The marked tissue 
